Factors associated with willingness to provide biospecimens for genetics research among African American cancer survivors
- 3 Downloads
This study evaluated factors associated with willingness to provide biospecimens for cancer genetic research among African American cancer survivors. A total of 200 African American adults diagnosed with breast, colon, and/or prostate cancers completed a self-administered survey. Family history information, beliefs about cancer research, cancer genetics and disparities knowledge, willingness to provide a biospecimen, and demographics were obtained. Chi-square, independent samples t tests, and logistic regression analyses were performed. Overall, 79% of this sample was willing to provide a biospecimen for cancer genetics research. Independent associations of willingness to provide a biospecimen existed among demographics (males (p = 0.041)), those who believed in the importance of genetic causes of cancer (p < 0.001), individuals who believe it is important to participate in genetics research (p < 0.001), and those who indicated they would participate in genetics research to help future generations (p = 0.026). Overall, 12.5–56% of participants demonstrated some level of genetics and cancer disparities. This study identified factors that may be incorporated into future research interventions to engage the African American cancer population in cancer genetics biobanking research.
KeywordsBiospecimens Willingness to participate Cancer genetics research African American cancer survivors Cancer health disparities
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was not required for this study as identifying information was not obtained. An informational preamble was provided and read by all individual participants included in the study. The Howard University Institutional Review Board approved of this study.
- Cancer Disparities - National Cancer Institute at the National Institutes of Health (2018) Retrieved from http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health-disparities. Accessed 23 Oct 2018
- Caswell-Jin JL, Gupta T, Hall E, Petrovchich IM, Mills MA, Kingham KE, Koff R, Chun NM, Levonian P, Lebensohn AP, Ford JM, Kurian AW (2018) Racial/ethnic differences in multiple-gene sequencing results for hereditary cancer risk. Genet Med 20(2):234–239. https://doi.org/10.1038/gim.2017.96 PubMedGoogle Scholar
- Cragun D, Scherr C, Camperlengo L, Vadaparampil ST, Pal T (2016) Evolution of hereditary breast cancer genetic services: are changes reflected in the knowledge and clinical practices of Florida providers? Genet Test Mol Biomarkers 20(10):569–578. https://doi.org/10.1089/gtmb.2016.0113 PubMedGoogle Scholar
- Dang JH, Rodriguez EM, Luque JS, Erwin DO, Meade CD, Chen MS, Jr (2014) Engaging diverse populations about biospecimen donation for cancer research. J Commun Genet 5(4):313–327. https://doi.org/10.1007/s12687-014-0186-0
- Hagiwara N, Berry-Bobovski L, Francis C, Ramsey L, Chapman RA, Albrecht TL (2014) Unexpected findings in the exploration of African American underrepresentation in biospecimen collection and biobanks. J Cancer Educ 29(3):580–587. https://doi.org/10.1007/s13187-013-0586-6 PubMedPubMedCentralGoogle Scholar
- Halbert CH, Gandy OH, Collier A, Shaker L (2006b) Intentions to participate in genetics research among African American smokers. Cancer Epidemiol Biomark Prev 15(1):150–153Google Scholar
- Johnson T, Fendrich M (2002) A validation of the Crowne-Marlowe social desirability scale. Unpublished manuscript. Retrieved from http://www.srl.uic.edu/publist/Conference/crownemarlowe.pdf. Accessed 23 Oct 2018
- Liu S, Seidel-Dugan C (2006) In search of p53 target genes for the therapeutic manipulation of cancer. Curr Opin Drug Discov Dev 9(2):176–183Google Scholar
- McQuillan GM, Porter KS, Agelli M, Kington R (2003) Consent for genetic research in a general population: the NHANES experience. Genet Med 5:35–42Google Scholar
- Moorman PG, Skinner CS, Evans JP, Newman B, Sorenson JR, Calingaert B, … Schildkraut JM (2004) Racial differences in enrolment in a cancer genetics registry. Cancer Epidemiol Biomark Prev 13(8):1349–1354Google Scholar
- National Cancer Institute (2012) PDQ® genetics of prostate cancer. Retrieved from http://cancer.gov/cancertopics/pdq/genetics/prostate/HealthProfessional. Accessed 23 Oct 2018
- Owens OL, Jackson DD, Thomas TL, Friedman DB, Hebert JR (2013) African-American men’s and women’s perceptions of clinical trials research: focusing on prostate cancer among a high risk population in the South. J Health Care Poor Underserved 2(4):1784–1800. https://doi.org/10.1353/hpu.2013.0187 Google Scholar
- Skloot R, Turpin B (2010) The immortal life of Henrietta Lacks. Crown Publishers, New YorkGoogle Scholar
- Streicher SA, Sanderson SC, Jabs EW, Diefenbach M, Smirnoff M, Peter I, … Richardson LD (2011) Reasons for participating and genetic information needs among racially and ethnically diverse biobank participants: a focus group study. J Community Genet 2(3):153–163. https://doi.org/10.1007/s12687-011-0052-2
- Thurman N, Ragin C, Heron DE, Alford RJ, Andraos-Selim C, Bondzi C, … Taioli E (2009) Comparison of knowledge and attitudes toward cancer among African Americans. Infect Agents Cancer 4(Suppl 1):S15. https://doi.org/10.1186/1750-9378-4-S1-S15
- U.S. Department of Health & Human Services, National Institutes of Health (2018) Precision medicine initiative, all of us research program. Retrieved from https://allofus.nih.gov/. Accessed 23 Oct 2018
- Zoon KC (2004) Future directions in cancer research: impact of the completion of the human genome. Toxic Pathol 32(Suppl 1):1–2Google Scholar